A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Cobicistat | CAS 1004316-88-4 - Request Quote

Picture of Cobicistat
SZ CAT No:SZ-C088001
CAS No
1004316-88-4
Mol.F.
C40H53N7O5S2
Mol.Wt.
776
Inv. Status
In Stock
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Cobicistat is chemically Thiazol-5-ylmethyl ((2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanamido)-1,6-diphenylhexan-2-yl)carbamate. Cobicistat is supplied with detailed characterization data compliant with regulatory guideline. Cobicistat can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cobicistat.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1004316-88-4

Purchase 1004316-88-4

Order 1004316-88-4

Enquire 1004316-88-4

price of 1004316-88-4

1004316-88-4 Supplier

1004316-88-4 Manufacturer

1004316-88-4 Exporter

buy high quality Cobicistat

Purchase Cobicistat

Cobicistat suppliers

Cobicistat manufacturers

Cobicistat price

Order Cobicistat

Enquire Cobicistat

Cobicistat cost

Cobicistat Supplier

Cobicistat Distributor

Cobicistat for Method Validation

Cobicistat Reference Standard

Cobicistat for ANDA Filing

Cobicistat for Forced Degradation Studies

Cobicistat Identification Standards

Cobicistat for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,